Composition for the prevention and/or treatment of disorders...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/722 (2006.01) A61K 31/205 (2006.01) A61P 3/06 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2391625

A composition is disclosed suitable for the prevention and/or treatment of disorders due to abnormal lipid metabo- lism, such as hypercholesterolaemia, atherosclerosis, hyperlipidaemia and obesity, and which can therefore take the form of a dietary supplement or of an actual medicine, comprising as characterising active ingredients: (a) propionyl L-carnitine or a pharmacologi- cally acceptable salt thereof, and (b) chitosan or its derivatives and congeners.

L'invention concerne une composition utilisée dans la prévention et/ou le traitement de troubles dus à un métabolisme lipidique anormal, tels que l'hypercholestérolémie, l'athérosclérose, l'hyperlipidémie et l'obésité, et qui peut donc prendre la forme d'un supplément alimentaire ou d'un médicament, comprenant comme principes actifs caractéristiques: (a) la L-carnitine de propionyle ou un de ses sels pharmaceutiquement acceptables, et (b) du chitosane ou ses dérivés et ses substances organoleptiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for the prevention and/or treatment of disorders... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for the prevention and/or treatment of disorders..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the prevention and/or treatment of disorders... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1707881

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.